Hip Replacement Market Companies Analysis

The global hip replacement market continues to expand steadily as aging populations, orthopedic disorders, and lifestyle-related conditions increase worldwide. The industry is projected to grow from US$ 6.92 Billion in 2024 to US$ 10.24 Billion by 2033, registering a compound annual growth rate (CAGR) of 4.45% between 2025 and 2033. This growth reflects rising surgical demand, technological innovation in implant design, and growing awareness of improved mobility outcomes.

Hip replacement surgery, also known as hip arthroplasty, involves replacing a damaged hip joint with a prosthetic implant. The procedure is primarily performed for conditions such as osteoarthritis, rheumatoid arthritis, avascular necrosis, hip fractures, and traumatic injuries. By relieving chronic pain and restoring joint function, hip replacement significantly improves patient quality of life and enables return to daily activities.

Rising obesity rates, sedentary lifestyles, sports injuries, and traffic accidents have contributed to increasing hip joint damage worldwide. Combined with longer life expectancy, these factors are driving consistent demand for both total and partial hip replacement procedures.

Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=hip-replacement-market-competitive-landscape-p.php

Market Drivers and Industry Trends

Several structural drivers are supporting market expansion:

• Aging global population prone to degenerative joint diseases

• Increasing prevalence of obesity and orthopedic complications

• Technological advancements in minimally invasive surgery

• Growing adoption of robotic-assisted and digital surgical systems

• Rising demand for improved implant durability and faster recovery

Minimally invasive techniques and robotic navigation systems are transforming surgical outcomes by improving precision and reducing post-operative complications. Surgeons and hospitals are increasingly adopting digital-enabled tools that enhance implant positioning and patient-specific customization.

Leading Companies in the Hip Replacement Market

1. Smith & Nephew plc

Founded: 1856
Headquarters: United Kingdom

Smith & Nephew develops and markets medical devices across advanced wound care, sports medicine, orthopedic reconstruction, and trauma. Its orthopedic division includes hip, knee, and shoulder replacement systems along with robotics-assisted technologies.

The company distributes products globally across Europe, Asia-Pacific, the Americas, the Middle East, and Africa. Its portfolio integrates digital surgical solutions and biologic products, strengthening its competitive position in hip arthroplasty innovation.

2. Johnson & Johnson

Established: 1886
Headquarters: United States

Johnson & Johnson operates in pharmaceuticals and medical devices, including orthopedic reconstruction. Through its medical technology segment, the company develops hip implants, surgical systems, and robotic-assisted solutions.

Its global manufacturing and distribution footprint spans North America, Europe, Asia-Pacific, and Latin America. Continuous investment in R&D and robotic surgical platforms reinforces its market leadership.

3. Integra LifeSciences

Founded: 1989
Headquarters: United States

Integra LifeSciences develops orthopedic hardware, advanced wound care products, and specialty implants. Its product lines include orthobiologics, surgical instruments, and collagen-based regenerative technologies.

The company serves hospitals, outpatient surgery centers, and specialty clinics through a global distribution network supported by direct sales representatives and partners.

4. Zimmer Biomet

Founded: 1927
Headquarters: United States

Zimmer Biomet is a leading musculoskeletal care company offering orthopedic reconstructive products, biologics, and robotic technologies. Its hip replacement systems are widely used across hospitals and surgical centers worldwide.

The company distributes through direct and distributor networks across the Americas, Europe, Asia-Pacific, and emerging markets. Digital integration and robotics-assisted surgery strengthen its competitive differentiation.

5. Stryker Corporation

Founded: 1941
Headquarters: United States

Stryker specializes in orthopedic implants, surgical navigation systems, and advanced medical technologies. Its orthopedic division includes hip replacement implants, surgical robotics, and digital workflow platforms.

Operating globally, Stryker maintains strong market presence through subsidiaries, branches, and independent distributors. Continuous innovation in implant materials and navigation systems drives its growth.

Sustainability Analysis

CONMED Corporation

CONMED Corporation integrates sustainability into its Environmental, Social, and Governance (ESG) framework. The company has implemented initiatives to reduce energy consumption, conserve water, and source environmentally responsible materials.

Strength – Commitment to Carbon Reduction

CONMED aims to reduce 90% of Scope 1, Scope 2, and selected Scope 3 emissions by 2050, based on a 2023 baseline. Its sustainability efforts also include eco-friendly manufacturing processes and responsible supply chain practices.

SWOT Analysis of Key Market Participants

Exactech Inc.

Strength – Established Product Portfolio

Exactech offers a wide range of joint replacement implants and surgical instruments across hip, knee, shoulder, and ankle segments. Its reputation for innovation and surgeon collaboration strengthens market positioning.

Opportunity – Post-Bankruptcy Restructuring

Following financial restructuring, Exactech has an opportunity to rebuild brand trust, enhance compliance, and reestablish market share through strategic investments and partnerships.

Arthrex Inc.

Strength – Leadership in Minimally Invasive Solutions

Arthrex develops over 1,000 new products annually, specializing in minimally invasive orthopedic solutions. Its commitment to surgeon training and education reinforces product adoption.

Opportunity – Expansion into Emerging Markets

Emerging healthcare markets present growth opportunities. By investing in localized training programs and partnerships, Arthrex can expand global reach and increase accessibility.

Medacta International SA

Strength – Personalized Surgical Innovation

Medacta focuses on patient-matched implants and kinematic alignment techniques. Its R&D investments and surgeon training programs enhance precision and patient outcomes.

Opportunity – Growth in Minimally Invasive Surgery

Increasing demand for faster recovery and customized procedures offers Medacta opportunities to expand surgical instrument and navigation system portfolios.

Recent Developments

• May 2025: Zimmer Biomet reported Q1 hip revenue of USD 495.8 million, reflecting strong adoption of its Z1 Triple-Taper Femoral Hip System.

• April 2025: Smith & Nephew reported Q1 sales of USD 1.407 billion, with regulatory approvals supporting product expansion.

• March 2025: Johnson & Johnson MedTech introduced the KINCISE 2 automated impaction device and expanded robotic-assisted surgical solutions.

These developments highlight the industry’s focus on automation, surgeon efficiency, and improved implant positioning.

Hip Replacement Market & Forecast

Historical Trends

Historically, hip replacement demand has grown steadily with aging demographics and improved surgical outcomes. The adoption of minimally invasive techniques and improved implant materials has increased procedural success rates.

Forecast Analysis

The projected growth to US$ 10.24 Billion by 2033 reflects consistent demand rather than rapid disruption. Growth will be driven by technological refinement, robotic assistance, and patient-specific implant development.

Market Share Dynamics

Market share remains concentrated among major multinational orthopedic manufacturers, supported by strong R&D pipelines and global distribution networks.

Company Analysis Framework

For each company—including Smith & Nephew PLC, Johnson & Johnson, Integra LifeSciences Corporation, Zimmer Biomet, Stryker, B. Braun Melsungen AG, Globus Medical Inc., MicroPort Scientific Corporation, Conformis Inc., Exactech Inc., Arthrex Inc., Medacta International SA, CONMED Corporation, Corin Group PLC, DJO Global Inc., Aesculap Implant Systems LLC, OMNIlife Science Inc., Wright Medical Group, LimaCorporate, and Mathys Ltd Bettlach—the following analysis is provided:

• Company Overview

• History and Mission

• Business Model and Operations

• Workforce and Leadership

• Strategic Initiatives and Partnerships

• Sustainability Strategy

• Renewable Energy Adoption

• Circular Economy Practices

• Product Portfolio and Pipeline

• Quality Standards and Benchmarking

• SWOT Assessment

• Revenue Analysis

Final Thoughts

The hip replacement market represents a stable and innovation-driven segment within the global medical device industry. With a projected CAGR of 4.45% through 2033, growth is anchored in demographic trends and continuous surgical advancements.

As robotic systems, personalized implants, and minimally invasive techniques become more prevalent, leading manufacturers will compete on precision, durability, and patient outcomes. Sustainability initiatives and regulatory compliance will also shape competitive positioning.

Ultimately, the industry’s success lies in its ability to restore mobility and improve quality of life for millions of patients worldwide—making hip replacement not only a medical necessity but also a transformative solution for aging and injured populations.